|
US3201389A
(en)
|
1962-09-24 |
1965-08-17 |
Kyowa Hakko Kogyo Kk |
Method for preparing ribonucleoside-5'-phosphates or their salts from ribonucleosides
|
|
US3451997A
(en)
|
1965-11-30 |
1969-06-24 |
Kyowa Hakko Kogyo Kk |
Monothio-phosphate ester catalysis for preparation of ribonucleoside derivatives
|
|
US4172896A
(en)
|
1978-06-05 |
1979-10-30 |
Dainippon Pharmaceutical Co., Ltd. |
Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
|
|
US4411995A
(en)
|
1981-09-28 |
1983-10-25 |
Massachusetts Institute Of Technology |
Synthesis of nicotinamide cofactors
|
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
|
GB9315856D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
|
US5541231A
(en)
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
|
ES2206965T3
(es)
|
1997-07-29 |
2004-05-16 |
Alcon Laboratories, Inc. |
Composiciones oftalmicas que contienen polimeros de galactomanana y borato.
|
|
US6110973A
(en)
|
1998-01-29 |
2000-08-29 |
Sepracor |
Methods for treating obesity and weight gain using optically pure (-)-bupropion
|
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
|
RS51031B
(sr)
|
2001-04-30 |
2010-10-31 |
Trommsdorff Gmbh & Co.Kg.Arzneimittel |
Farmaceutski aktivni estri uridina
|
|
US7977049B2
(en)
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
|
US20040224039A1
(en)
|
2003-02-12 |
2004-11-11 |
Donald Brucker |
Compositions and methods for the treatment of diseases and disorder associated with oxidative damage
|
|
US6887855B2
(en)
*
|
2003-03-17 |
2005-05-03 |
Pharmion Corporation |
Forms of 5-azacytidine
|
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
|
EP1654002B2
(en)
|
2003-08-07 |
2014-01-29 |
Allergan, Inc. |
Compositions for delivery of therapeutics into the eyes
|
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
AU2004324323A1
(en)
|
2003-10-31 |
2006-06-15 |
Robarts Research Institute |
Methods and formulations for protecting cells, and for treating diseases and conditions by optimising the intracellular concentration of NAD
|
|
DK1755391T3
(en)
|
2004-06-04 |
2016-02-08 |
Univ Washington |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF neuropathies
|
|
CA2599987A1
(en)
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
Fused heterocyclic compounds and their use as sirtuin modulators
|
|
US20070149466A1
(en)
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
|
US7855289B2
(en)
|
2005-08-04 |
2010-12-21 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
JP5063878B2
(ja)
|
2005-08-30 |
2012-10-31 |
扶桑薬品工業株式会社 |
硫化水素塩を含有する消化器系疾患の予防／治療用組成物
|
|
US20080020413A1
(en)
*
|
2006-03-29 |
2008-01-24 |
Columbia University |
Crystalline visfatin and methods therefor
|
|
CA2646674A1
(en)
|
2006-04-20 |
2007-11-01 |
Fred Hutchinson Cancer Research Center |
Use of chalcogenides for treating shock and other adverse conditions
|
|
US20080318892A1
(en)
|
2006-04-28 |
2008-12-25 |
John Geoffrey Pickering |
Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad
|
|
WO2007136744A1
(en)
*
|
2006-05-19 |
2007-11-29 |
The Johns Hopkins University |
Crystal structure of a substrate complex of nampt/pbef/visfatin
|
|
WO2008091710A2
(en)
*
|
2007-01-26 |
2008-07-31 |
Washington University |
Methods and compositions for treating neuropathies
|
|
CN101497638B
(zh)
|
2008-01-30 |
2012-09-26 |
中国科学院大连化学物理研究所 |
一种nad+类似物及其合成和应用
|
|
US11219696B2
(en)
|
2008-12-19 |
2022-01-11 |
Nationwide Children's Hospital |
Delivery of polynucleotides using recombinant AAV9
|
|
CN101601679B
(zh)
|
2009-03-17 |
2011-08-10 |
中国人民解放军第二军医大学 |
一种烟酰胺单核苷酸的应用
|
|
WO2010135520A1
(en)
|
2009-05-20 |
2010-11-25 |
Chimerix, Inc. |
Compounds, compositions and methods for treating viral infection
|
|
KR20110061909A
(ko)
*
|
2009-12-02 |
2011-06-10 |
삼성전자주식회사 |
도펀트로 도핑된 그라펜 및 이를 이용한 소자
|
|
WO2011130595A2
(en)
|
2010-04-15 |
2011-10-20 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin activators and activation assays
|
|
JP5663576B2
(ja)
|
2010-07-06 |
2015-02-04 |
秀則 上西 |
神経突起伸長剤
|
|
AR082885A1
(es)
|
2010-09-03 |
2013-01-16 |
Genentech Inc |
Compuestos y composiciones para la inhibicion de nampt
|
|
CN106243023A
(zh)
|
2010-09-03 |
2016-12-21 |
福马Tm有限责任公司 |
用于抑制nampt的胍化合物和组合物
|
|
RU2617424C2
(ru)
|
2010-09-03 |
2017-04-25 |
ФОРМА ТиЭм, ЭлЭлСИ |
Новые соединения и композиции для ингибирования nampt
|
|
WO2012094343A1
(en)
|
2011-01-05 |
2012-07-12 |
Trilink Biotechnologies |
Chemically substituted thermosensitive probes and cofactors for hot start ligation
|
|
US20140065099A1
(en)
|
2011-02-15 |
2014-03-06 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Methods of Treating Mitochondrial Dysfunction
|
|
US20120107888A1
(en)
|
2011-02-17 |
2012-05-03 |
Qteros, Inc. |
Modulation of fermentation products through vitamin supplementation
|
|
WO2012150952A1
(en)
|
2011-05-04 |
2012-11-08 |
Forma Tm, Llc |
Novel compounds and compositions for the inhibition of nampt
|
|
US20120328526A1
(en)
|
2011-06-27 |
2012-12-27 |
University Of Maryland, Baltimore |
Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof
|
|
AU2012276037A1
(en)
|
2011-06-29 |
2014-02-13 |
Mayo Foundation For Medical Education And Research |
Small molecule CD38 inhibitors and methods of using same
|
|
CA2865509A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Amido-benzyl sulfone and sulfoxide derivatives
|
|
WO2013130943A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Alkyl-and di-substituted amido-benzyl sulfonamide derivatives
|
|
WO2013127268A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech,Inc. |
Amido-benzyl sulfone and sulfonamide derivatives
|
|
PT2820008T
(pt)
|
2012-03-02 |
2017-05-05 |
Genentech Inc |
Amidas amido-espirocíclicas e derivados de sulfonamidas
|
|
JP2015508785A
(ja)
|
2012-03-02 |
2015-03-23 |
ジェネンテック， インコーポレイテッド |
ピリジニル及びピリミジニルスルホキシド及びスルホン誘導体
|
|
ES2785303T3
(es)
|
2012-07-16 |
2020-10-06 |
Univ Cornell |
Nicotinamida ribósido para tratar la pérdida auditiva
|
|
WO2014059034A2
(en)
*
|
2012-10-09 |
2014-04-17 |
President And Fellows Of Harvard College |
Nad biosynthesis and precursors for the treatment and prevention of cancer and proliferation
|
|
CN102876759A
(zh)
*
|
2012-10-29 |
2013-01-16 |
尚科生物医药（上海）有限公司 |
尼克酰胺腺嘌呤二核苷酸的制备方法
|
|
WO2014074715A1
(en)
|
2012-11-07 |
2014-05-15 |
Genentech, Inc. |
Cyclopropyl amide derivatives
|
|
WO2014111906A1
(en)
|
2013-01-21 |
2014-07-24 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Bioluminescence imaging of small biomolecules
|
|
US20140271355A1
(en)
|
2013-03-15 |
2014-09-18 |
Sabre Intellectual Property Holdings Llc |
Apparatus and process for focused gas phase application of biocide
|
|
EP2968306B1
(en)
|
2013-03-15 |
2023-06-07 |
Washington University |
Administration of nicotinamide mononucleotide in the treatment of dry eye
|
|
GB201313465D0
(en)
|
2013-07-29 |
2013-09-11 |
Queens University Of The Belfast |
Methods of preparing nicotinamide riboside and derivatives thereof
|
|
WO2015069860A1
(en)
|
2013-11-06 |
2015-05-14 |
President And Fellows Of Harvard College |
Biological production of nad precursors and analogs
|
|
US10398701B2
(en)
|
2013-11-12 |
2019-09-03 |
Ortho-Nutra, Llc |
Theacrine-based supplement and method of use thereof in a synergistic combination with caffeine
|
|
BR112016010422B1
(pt)
|
2013-11-12 |
2021-08-31 |
Ortho-Nutra, Llc |
Suplemento dietético e método de tratamento para melhorar o desempenho ou energia física em um indivíduo
|
|
US20160279161A1
(en)
|
2013-11-14 |
2016-09-29 |
Newsouth Innovation Pty Limited |
Senescence and senescence associated secretory phenotype
|
|
CN104367587B
(zh)
|
2013-12-06 |
2018-06-29 |
中国人民解放军第二军医大学 |
烟酰胺单核苷酸在制备促脑缺血后神经再生药物中的应用
|
|
US10301268B2
(en)
|
2014-03-13 |
2019-05-28 |
The Salk Institute For Biological Studies |
Analogs of fexaramine and methods of making and using
|
|
US20150258052A1
(en)
|
2014-03-13 |
2015-09-17 |
Salk Institute For Biological Studies |
Methods of using fexaramine and agents that increase sympathetic nervous system activity to promote browning of white adipose tissue
|
|
WO2015138969A1
(en)
|
2014-03-13 |
2015-09-17 |
Salk Institute For Biological Studies |
Analogs of fexaramine and methods of making and using
|
|
AU2015270130A1
(en)
|
2014-06-02 |
2016-12-15 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Preparation and use of crystalline beta-D-nicotinamide riboside
|
|
US20170087180A1
(en)
|
2014-06-03 |
2017-03-30 |
Sulfagenix, Inc. |
Methods and compositions for treating nitric oxide deficiency disorders and related conditions
|
|
CN106715455A
(zh)
|
2014-06-06 |
2017-05-24 |
葛兰素史密斯克莱知识产权（第2 号）有限公司 |
烟酰胺核苷类似物及其药物组合物和用途
|
|
US10323058B2
(en)
|
2014-07-24 |
2019-06-18 |
W. R. Grace & Co.-Conn. |
Crystalline form of nicotinamide riboside
|
|
US10653782B2
(en)
|
2014-11-25 |
2020-05-19 |
Nortwestern University |
Retroviral particles expressing Sirt1 embedded within PPCN
|
|
AU2015362283B2
(en)
|
2014-12-09 |
2020-07-30 |
Amorepacific Corporation |
Composition for activating longevity gene
|
|
AU2016229319B2
(en)
|
2015-03-09 |
2020-05-07 |
W.R. Grace & Co.-Conn. |
Crystalline form of nicotinamide riboside
|
|
CN104817604B
(zh)
|
2015-03-16 |
2017-08-04 |
邦泰生物工程(深圳)有限公司 |
一种β‑烟酰胺单核苷酸的纯化方法
|
|
WO2016149672A1
(en)
|
2015-03-18 |
2016-09-22 |
The Regents Of The University Of California |
Methods of preventing and reversing stem cell aging
|
|
MX2017015496A
(es)
|
2015-06-04 |
2018-08-01 |
Chromadex Inc |
Fosforilacion selectiva sin disolvente.
|
|
WO2016210232A1
(en)
|
2015-06-25 |
2016-12-29 |
N.V. Perricone Llc |
Niacinamide mononucleotide formulations for skin aging
|
|
CN108137639B
(zh)
|
2015-08-05 |
2021-10-08 |
麦德龙国际生物科技有限责任公司 |
烟酰胺单核苷酸衍生物及其用途
|
|
TW201713774A
(zh)
|
2015-08-06 |
2017-04-16 |
Kohjin Life Sciences Co Ltd |
含有β-菸鹼醯胺單核苷酸的酵母萃取物及其製造方法
|
|
GB2542881B
(en)
|
2015-10-02 |
2020-01-01 |
Carr Andrew |
Crystal forms of ß-nicotinamide mononucleotide
|
|
RU2768936C2
(ru)
|
2015-10-07 |
2022-03-25 |
Джоэль УЙСЕНГА |
Нормализация функций биологических путей для защиты от и устранения нарушений, возникающих вследствие старения человека
|
|
US10611790B2
(en)
|
2015-11-02 |
2020-04-07 |
Mitobridge, Inc. |
Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
|
|
ES2812456T3
(es)
|
2015-12-21 |
2021-03-17 |
Showa Denko Kk |
Derivado de mononucleótido de nicotinamida y sal del mismo, método para producir el mismo, agente tópico, cosmético y aditivo alimentario
|
|
EP3187180A1
(en)
|
2015-12-28 |
2017-07-05 |
Ludwig-Maximilians-Universität München |
Adenosylhomocysteinase binding substances for medical use
|
|
US11248018B2
(en)
|
2016-02-23 |
2022-02-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Process for preparation of nicotinamide riboside (NR) and cosmetic composition comprising (NR and a phosphate-binding agent
|
|
EP3429354A4
(en)
|
2016-03-16 |
2020-03-25 |
Chromadex Inc. |
CONJUGATES OF VITAMIN B AND AMINO ACIDS OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYLE RIBOSIDES DERIVATIVES THEREOF, AND PROCESSES FOR THEIR PREPARATION
|
|
CN109640984A
(zh)
|
2016-04-20 |
2019-04-16 |
可劳迈戴斯有限公司 |
烟酸核苷或烟酰胺核苷衍生物及其还原的衍生物作为增加nad+的前体的用途
|
|
WO2017218580A1
(en)
|
2016-06-14 |
2017-12-21 |
Rejuvenation Therapeutics Corporation |
Synthetic methods for the preparation of nicotinamide riboside and related compounds
|
|
WO2018023210A1
(zh)
|
2016-07-30 |
2018-02-08 |
邦泰生物工程(深圳)有限公司 |
一种制备烟酰胺单核苷酸的方法
|
|
WO2018023207A1
(zh)
|
2016-07-30 |
2018-02-08 |
邦泰生物工程(深圳)有限公司 |
一种制备烟酰胺单核苷酸的方法
|
|
CN107922952B
(zh)
|
2016-07-30 |
2021-04-27 |
邦泰生物工程(深圳)有限公司 |
一种制备烟酰胺单核苷酸的方法
|
|
CN108026535B
(zh)
|
2016-07-30 |
2021-04-27 |
邦泰生物工程(深圳)有限公司 |
一种制备烟酰胺单核苷酸的方法
|
|
CN108026132B
(zh)
|
2016-07-30 |
2021-08-13 |
邦泰生物工程(深圳)有限公司 |
一种烟酰胺单核苷酸的纯化方法
|
|
US11040996B2
(en)
|
2016-07-30 |
2021-06-22 |
Bontac Bio-Engineering(Shenzhen) Co., Ltd |
Method for preparing nicotinamide mononucleotide (NMN)
|
|
WO2018047715A1
(ja)
*
|
2016-09-06 |
2018-03-15 |
協和発酵バイオ株式会社 |
β－ニコチンアミドモノヌクレオチドの結晶及びその製造方法
|
|
EP3512158B1
(en)
|
2016-09-09 |
2021-08-18 |
Nec Corporation |
Transmitting device, receiving device, quantum key distribution method, and quantum key distribution program for quantum key distribution system
|
|
US20200009170A1
(en)
|
2016-09-13 |
2020-01-09 |
Megumi Tanaka |
Sleep display agent property and method for improving sleep disorders
|
|
EP3513795B1
(en)
|
2016-09-13 |
2023-07-19 |
Megumi Tanaka |
Visual function improvement agent, and method for improving visual function
|
|
EP3538099A4
(en)
|
2016-11-11 |
2020-06-17 |
The Queen's University of Belfast |
EFFICIENT AND SCALABLE SYNTHESIS OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS OF THEM, ADENYLYDINUCLEOTIDE CONJUGATES THEREOF AND NEW-WAY CRYSTALS
|
|
JP2020504722A
(ja)
|
2016-12-21 |
2020-02-13 |
ニューサウス イノベーションズ ピーティーワイ リミテッド |
血管密度を増加させる方法
|
|
CN106755209B
(zh)
|
2016-12-29 |
2021-07-23 |
苏州汉酶生物技术有限公司 |
一种酶法制备β-烟酰胺单核苷酸的方法
|
|
EP3568488A4
(en)
|
2017-01-13 |
2020-09-23 |
The Regents of The University of Colorado, A Body Corporate |
METHODS OF TREATMENT OF HYPERTENSION AND ARTERIAL RIGIDITY
|
|
EP3578639A4
(en)
|
2017-01-31 |
2020-07-08 |
Oriental Yeast Co., Ltd. |
AGENT FOR ACCELERATING THE GROWTH OF STEM CELLS WITH DIFFERENTIATION POTENTIAL
|
|
JP6920071B2
(ja)
|
2017-02-16 |
2021-08-18 |
ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ |
アディポネクチン分泌向上剤
|
|
CA3059228C
(en)
|
2017-04-05 |
2025-03-18 |
Cornell University |
BETA-NICOTINE ESTER NUCLEOTIDES AND PREPARATION METHODS
|
|
CA3071561A1
(en)
|
2017-07-31 |
2019-02-07 |
Newsouth Innovations Pty Limited |
Methods for increasing fertility
|
|
WO2019152416A1
(en)
|
2018-01-30 |
2019-08-08 |
Metro International Biotech, Llc |
Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof
|
|
WO2020072497A1
(en)
|
2018-10-01 |
2020-04-09 |
Cornell University |
Methyl and ethyl nicotinate-riboside-5-phosphates, preparation thereof and methods of use thereof
|
|
CN113301898B
(zh)
|
2018-12-10 |
2022-11-18 |
可劳迈戴斯有限公司 |
烟酰核苷及其衍生物的晶型，及其制备方法
|
|
JP2022523864A
(ja)
|
2019-03-22 |
2022-04-26 |
メトロ インターナショナル バイオテック，エルエルシー |
ニコチンアミドリボシドのリン誘導体を含む組成物及びニコチンアミドアデニンジヌクレオチドのモジュレーションのための方法
|
|
US11939348B2
(en)
|
2019-03-22 |
2024-03-26 |
Metro International Biotech, Llc |
Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
|
|
US10618927B1
(en)
|
2019-03-22 |
2020-04-14 |
Metro International Biotech, Llc |
Compositions and methods for modulation of nicotinamide adenine dinucleotide
|
|
EP4153323A1
(fr)
|
2020-05-20 |
2023-03-29 |
Nuvamid SA |
Compositions cosmetiques anti-age comprenant du nmn
|
|
KR20240020716A
(ko)
|
2021-05-27 |
2024-02-15 |
메트로 인터내셔널 바이오테크 엘엘씨 |
니코틴산 모노뉴클레오타이드 및 이의 에스터의 결정질 고체 및 제조 및 사용 방법
|